Could Dyne Therapeutics' (DYN) AMCP Spotlight Reveal How New FDA Leadership May Shape Its Pipeline? [Yahoo! Finance]
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines [TheStreet.com]
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
Dyne Therapeutics Advances Rare Disease Pipeline With Pivotal Trials And Data [Yahoo! Finance]
Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs [Yahoo! Finance]